Aarey Drugs & Pharmaceuticals Limited — Important, 03-06-2025: Updates

Aarey Drugs reported revenue of ₹108.10 Cr with a PBT of ₹16.25 Cr and net profit of ₹7.15 Cr for the quarter. Total assets declined to ₹238.27 Cr, impacted by lower trade receivables and inventories. Operating cash flow rose sharply to ₹120.64 Cr, aided by working capital improvements. New plant and machinery were capitalized; depreciation will commence once fully operational, indicating potential future cost impact.